Skip to NavigationSkip to content

Mundipharma names new President and CEO

Published on: 13/12/17

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as its new President and Chief Executive Officer.

Martinez takes over the reins at the company from predecessor Anthony Mattessich who held the role for 12 years, and has himself worked with Mundipharma for 14 years since joining in Spain in 2003. Over time, he transitioned to become General Manager of Mundipharma’s Spanish business, where he led a corporate turnaround between 2008 and 2014. In 2014, Martinez was appointed Managing Director of Napp Pharmaceuticals in the UK, against driving a robust transformation programme with the company. Most recently, Martinez held the role of Regional Director of Northern Europe at Mundipharma before being appointed in October 2016 as European Director of Commercial Operations.

The company said on release of the news: “With his proven strategic, financial and operational capabilities together with his strong commitment to commercialization and growth, the Board of Directors is confident Alberto will enhance value for business partners, employees and patients alike.”

According to the company, Martinez’s remit will focus on “expanding and diversifying the network’s product portfolio, where the network is open to new alliance opportunities at all stages of asset maturity across the commercial platforms of specialist-driven primary care, specialty care (including emergency care, oncology and biosimilars) and established brands”. Based at the Mundipharma network campus in Cambridge, Martinez will also “oversee European business development, HR and finance functions.  Additionally, the functions of research and development, global manufacturing and supply chain and IT will also fall under Alberto’s new remit.”

“I feel honoured and privileged to be given the opportunity to lead the Mundipharma organisations in Europe in the next chapter of our evolution and success,” Martinez commented. “I am committed to ensure that we remain ambitious and agile so we continue to bring valuable and innovative medicines to patients and healthcare providers as a successful, diversified and forward-thinking organisation.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches